185 related articles for article (PubMed ID: 33803437)
1. Synthesis and Pharmacological In Vitro Investigations of Novel Shikonin Derivatives with a Special Focus on Cyclopropane Bearing Derivatives.
Kretschmer N; Hufner A; Durchschein C; Popodi K; Rinner B; Lohberger B; Bauer R
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803437
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells.
Durchschein C; Hufner A; Rinner B; Stallinger A; Deutsch A; Lohberger B; Bauer R; Kretschmer N
Molecules; 2018 Oct; 23(11):. PubMed ID: 30380765
[TBL] [Abstract][Full Text] [Related]
3. SK119, a Novel Shikonin Derivative, Leads to Apoptosis in Melanoma Cell Lines and Exhibits Synergistic Effects with Vemurafenib and Cobimetinib.
Kretschmer N; Durchschein C; Hufner A; Rinner B; Lohberger B; Bauer R
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628494
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of cinnamic acyl shikonin derivatives.
Lin HY; Chen W; Shi J; Kong WY; Qi JL; Wang XM; Yang YH
Chem Biol Drug Des; 2013 Feb; 81(2):275-83. PubMed ID: 23066914
[TBL] [Abstract][Full Text] [Related]
5. Naphthoquinones from Onosma paniculata induce cell-cycle arrest and apoptosis in melanoma Cells.
Kretschmer N; Rinner B; Deutsch AJ; Lohberger B; Knausz H; Kunert O; Blunder M; Boechzelt H; Schaider H; Bauer R
J Nat Prod; 2012 May; 75(5):865-9. PubMed ID: 22530779
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of heterocyclic carboxylic acyl shikonin derivatives.
Wang XM; Lin HY; Kong WY; Guo J; Shi J; Huang SC; Qi JL; Yang RW; Gu HW; Yang YH
Chem Biol Drug Des; 2014 Mar; 83(3):334-43. PubMed ID: 24118825
[TBL] [Abstract][Full Text] [Related]
7. Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation.
Yang YY; He HQ; Cui JH; Nie YJ; Wu YX; Wang R; Wang G; Zheng JN; Ye RD; Wu Q; Li SS; Qian F
Chem Biol Drug Des; 2016 Jun; 87(6):895-904. PubMed ID: 26804061
[TBL] [Abstract][Full Text] [Related]
8. Novel shikonin derivatives targeting tubulin as anticancer agents.
Guo J; Chen XF; Liu J; Lin HY; Han HW; Liu HC; Huang SC; Shahla BK; Kulek A; Qi JL; Wang XM; Ling LJ; Yang YH
Chem Biol Drug Des; 2014 Nov; 84(5):603-15. PubMed ID: 24797889
[TBL] [Abstract][Full Text] [Related]
9. Comparative Gene Expression Analysis in WM164 Melanoma Cells Revealed That
Kretschmer N; Deutsch A; Durchschein C; Rinner B; Stallinger A; Higareda-Almaraz JC; Scheideler M; Lohberger B; Bauer R
Molecules; 2018 Oct; 23(11):. PubMed ID: 30380804
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents.
Huang G; Zhao HR; Meng QQ; Zhang QJ; Dong JY; Zhu BQ; Li SS
Eur J Med Chem; 2018 Jan; 143():166-181. PubMed ID: 29174813
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization.
Lin HY; Li ZK; Bai LF; Baloch SK; Wang F; Qiu HY; Wang X; Qi JL; Yang RW; Wang XM; Yang YH
Biochem Pharmacol; 2015 Jul; 96(2):93-106. PubMed ID: 25957661
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of Chalcone-Containing Shikonin Derivatives as Inhibitors of Tubulin Polymerization.
Qiu HY; Wang F; Wang X; Sun WX; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH
ChemMedChem; 2017 Mar; 12(5):399-406. PubMed ID: 28211616
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Shao YY; Yin Y; Lian BP; Leng JF; Xia YZ; Kong LY
Eur J Med Chem; 2020 Mar; 190():112105. PubMed ID: 32035399
[TBL] [Abstract][Full Text] [Related]
14. Shikonin induces apoptosis and prosurvival autophagy in human melanoma A375 cells via ROS-mediated ER stress and p38 pathways.
Liu Y; Kang X; Niu G; He S; Zhang T; Bai Y; Li Y; Hao H; Chen C; Shou Z; Li B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):626-635. PubMed ID: 30873870
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Wang R; Zhang X; Song H; Zhou S; Li S
Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
[TBL] [Abstract][Full Text] [Related]
16. Targeting Cell Necroptosis and Apoptosis Induced by Shikonin via Receptor Interacting Protein Kinases in Estrogen Receptor Positive Breast Cancer Cell Line, MCF-7.
Shahsavari Z; Karami-Tehrani F; Salami S
Anticancer Agents Med Chem; 2018; 18(2):245-254. PubMed ID: 28933271
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of fluoroacylshikonin as an anticancer agent.
Kong WY; Chen XF; Shi J; Baloch SK; Qi JL; Zhu HL; Wang XM; Yang YH
Chirality; 2013 Nov; 25(11):757-62. PubMed ID: 23908135
[TBL] [Abstract][Full Text] [Related]
18. Identification of new shikonin derivatives as STAT3 inhibitors.
Qiu HY; Fu JY; Yang MK; Han HW; Wang PF; Zhang YH; Lin HY; Tang CY; Qi JL; Yang RW; Wang XM; Zhu HL; Yang YH
Biochem Pharmacol; 2017 Dec; 146():74-86. PubMed ID: 29066190
[TBL] [Abstract][Full Text] [Related]
19. Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.
Qiu HY; Zhu X; Luo YL; Lin HY; Tang CY; Qi JL; Pang YJ; Yang RW; Lu GH; Wang XM; Yang YH
Sci Rep; 2017 Jun; 7(1):2863. PubMed ID: 28588262
[TBL] [Abstract][Full Text] [Related]
20. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor.
Yang F; Chen Y; Duan W; Zhang C; Zhu H; Ding J
Int J Cancer; 2006 Sep; 119(5):1184-93. PubMed ID: 16570288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
